SHS has sold its stake in pharmaceutical logistics business Single Use Support (SUS) to US-based pharmaceutical business Pall.
MetaCompliance generated £6m in revenues in the year ending on 31 March 2020
Rabobank is to acquire a 34% stake in the healthcare platform via its Corporate Investments arm
Nutrisens management team, led by CEO Georges Devesa, retains a significant stake in the company
Intention to list comes four years after the GP acquired the company via its fourth fund